gene-editing

Mainland Chinese institutional fund managers have increased investments in Hong Kong-listed biotechnology stocks due to attractive valuations and a surge in cross-border licensing deals. E Fund Management, China's largest mutual fund manager, acquired a 7% stake in Biocytogen Pharmaceuticals by purchasing 91,500 shares at HK$46.90 each.

The EU's efforts to advance gene-editing may face challenges due to complex wine market regulations, potentially leaving gene-edited Pinot Noir and Riesling in an uncertain legal position.

A US-based team has achieved promising results using an improved CRISPR method to gene-edit human embryos. However, a significant issue remains unresolved, raising ongoing concerns about safety and ethical implications.

A court ruling has challenged UK gene-editing rules, raising new questions about the labelling of gene-edited food. The decision highlights regulatory uncertainties in the field of genetic modification.

Eli Lilly’s gene-editing data shows promise for treating high cholesterol, an AI drug discovery CEO addressed industry hype, and the new interim FDA chief has received positive initial reactions. The article highlights key biotech developments impacting science and regulatory landscapes.